Utama › Kanser Kolon › Virginia › Arlington
Kajian klinikal Kanser Kolon di Arlington, VA
15 kajian untuk Kanser Kolon sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Mengambil pesertaFasa 3
- Virginia Cancer Specialists, PC ( Site 0069), Fairfax · 11 mi jauh
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
- ALX Center 2, Fairfax · 11 mi jauh
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, Fairfax · 11 mi jauh
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11 mi jauh
- Virginia Cancer Specialists, PC, Reston · 14 mi jauh
- dan 1 lagi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Mengambil pesertaFasa 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi jauh
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Mengambil peserta
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi jauh
- Kaiser Permanente-Burke Medical Center, Burke · 11 mi jauh
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Mengambil pesertaFasa 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi jauh
- Kaiser Permanente-Burke Medical Center, Burke · 11 mi jauh
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, Fairfax · 11 mi jauh
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Next Oncology Virginia, Fairfax · 11 mi jauh
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Virginia, Fairfax · 11 mi jauh
Kajian Kanser Kolon di bandar lain
- Boston, MA22 kajian
- New York City, NY22 kajian
- Houston, TX20 kajian
- Nashville, TN16 kajian
- Los Angeles, CA16 kajian
- St. Louis, MO15 kajian
- Chicago, IL14 kajian
- Baldwin Park, CA14 kajian
- San Antonio, TX14 kajian
- Tampa, FL13 kajian
- Baltimore, MD13 kajian
- Washington, DC12 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara46 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.